Nektar Therapeutics (NKTR) Other Non-Current Assets (2010 - 2026)

Nektar Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 108.44% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (up 108.44% YoY), while the FY2025 annual figure was $14.1 million, up 204.28% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $11.2 million, down from $14.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $33.1 million in Q3 2024, with the low at $1.4 million in Q1 2023.
• The 5-year median for Other Non-Current Assets is $4.6 million (2023), against an average of $6.4 million.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 630.78% in 2024, then slumped 84.4% in 2025.
• Nektar Therapeutics' Other Non-Current Assets stood at $2.2 million in 2022, then jumped by 106.86% to $4.6 million in 2023, then rose by 0.06% to $4.6 million in 2024, then surged by 204.28% to $14.1 million in 2025, then retreated by 20.53% to $11.2 million in 2026.
• Business Quant data shows NKTR's Other Non-Current Assets at $11.2 million in Q1 2026, $14.1 million in Q4 2025, and $5.2 million in Q3 2025.